Literature DB >> 12131632

Decision rule and utility of routine urine toxicology screening of trauma patients.

M I Langdorf1, S E Rudkin, K Dellota, J C Fox, S Munden.   

Abstract

The objective of this study was to determine the impact of urine drug screening of major trauma victims on patient care and derive a decision rule for selective screening. Retrospective chart review of 170 trauma patients at a Level I Trauma Center, certified by the American College of Surgeons, was undertaken. The decision rule was developed by Classification and Regression Tree (CART) analysis to maximize sensitivity, with secondary attention to specificity. Eighty-nine percent of trauma patients were screened, while 26.0% had positive tests for illicit drugs. Serum ethanol was positive in 31.2%, over the legal limit of 0.08 g/dl. Both a legally intoxicated ethanol level and positive illicit drug screen were found in 11.0%. Additionally, 42.5% of patients with a positive illicit drug screen were also intoxicated (blood alcohol level above legal limit). Conversely, 35.4% of legally intoxicated patients also had positive illicit screens. Drug treatment referral occurred in 17.5% of positive drug screens. For urgent surgery, median time to drug screen result was 117 min, while median time to operation was 110 min. Of operative patients, 57% had the drug screen result recorded on the chart at any time, but only 14.3% of illicit screens were noted in the anaesthesia record. For all patients with and without operations, 71.1% had the result noted on the chart. We derived a 'low risk rule' to identify most patients with positive illicit drug screens (95% sensitivity, 55% specificity, 66% positive and 93% negative predictive values; accuracy 74%), while limiting the number of unnecessary tests. The rule avoids screening 48% of patients, missing only 5% of true positives. It is concluded that urine screening for illicit drugs in trauma patients can be performed selectively according to a decision rule based on demographics, mechanism of injury and time of presentation. This rule, which captures most positive screens while eliminating screening in low risk patients, could result in significant cost savings. Only prospective validation of these rules in patient populations of other trauma centres will offer confidence that the decision points are valid. Urine drug screening infrequently affected patient management or resulted in drug treatment referral in our sample. We call for increased vigilance in recording results and referring patients for treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12131632     DOI: 10.1097/00063110-200206000-00003

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  6 in total

1.  Comparison of Objective Screening and Self-Report for Alcohol and Drug Use in Traumatically Injured Patients.

Authors:  Lauren M Sakai; Thomas J Esposito; Hieu H Ton-That; Ellen C Omi; Elizabeth J Kovacs; Carol R Schermer
Journal:  Alcohol Treat Q       Date:  2012-10-12

2.  Polycystic Kidney Disease with Renal failure Presenting as Incarcerated Inguinal Hernia in the ED.

Authors:  Eric F Silman; Bharath Chakravarthy; Federico Vaca; Mark I Langdorf
Journal:  West J Emerg Med       Date:  2009-02

3.  Retrospective analysis of alcohol testing in trauma team activation patients at a Canadian tertiary trauma centre.

Authors:  Mete Erdogan; Nelofar Kureshi; Saleema A Karim; John M Tallon; Mark Asbridge; Robert S Green
Journal:  BMJ Open       Date:  2018-11-13       Impact factor: 2.692

4.  Incidence and impact of undisclosed cocaine use in emergency department chest pain and trauma patients.

Authors:  Guillermo Burillo-Putze; Juan María Borreguero León; Jose Antonio García Dopico; Jose Francisco Fernández Rodríguez; Maria Angeles Pérez Carrillo; Maria Jesús Jorge Pérez; Antonia María de Vera González; Eva Vallbona Afonso; Alejandro Jiménez Sosa
Journal:  Int J Emerg Med       Date:  2008-06-07

5.  Trauma activation patients: evidence for routine alcohol and illicit drug screening.

Authors:  C Michael Dunham; Thomas J Chirichella
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

6.  CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.

Authors:  Hemant Kulkarni; Brian K Agan; Vincent C Marconi; Robert J O'Connell; Jose F Camargo; Weijing He; Judith Delmar; Kenneth R Phelps; George Crawford; Robert A Clark; Matthew J Dolan; Sunil K Ahuja
Journal:  PLoS One       Date:  2008-09-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.